Octagam (Immune Globulin Intravenous (human); Liquid Preparation: Market Withdrawal – Risk of Thromboembolic Events

Audience: Risk Manager, Pediatrics, Neurology [UPDATED 09/24/2010] Octapharma USA and FDA notified healthcare professionals that, effective immediately, Octapharma is initiating a voluntary market withdrawal of ALL lots of Octagam currently in the…



No related posts.